Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma (HypoResus)
Field Trial of Hypotensive Resuscitation Versus Standard Resuscitation in Patients With Hemorrhagic Shock After Trauma: A Pilot Trial
Sponsor: Canadian Institutes of Health Research (CIHR)
A PHASE2 clinical study on Blunt Trauma and Hemorrhagic Shock, this trial is completed. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .